| Molecular formula | C47H58N12O6 |
|---|
| Molecular weight | 887 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 6918297 |
|---|
What Hexarelin Is
Hexarelin is a synthetic peptide compound identified by PubChem CID 6918297, with a molecular formula of C47H58N12O6. It has no approved drug label from the FDA and is classified as an unapproved research compound. No dosing, administration, or efficacy claims can be made because no regulatory review of its safety or effectiveness has been completed.
Trial Footprint
Based on the data available, there are no registered clinical trials for hexarelin at this time. No trial records, sample studies, or reported outcomes exist in the dataset reviewed for this monograph.
FAQ
No, hexarelin does not have FDA approval and no FDA label exists for it. It is classified as an unapproved research compound.
Hexarelin is identified by PubChem CID 6918297 and has a molecular formula of C47H58N12O6. This identifier allows it to be referenced consistently in chemical and research databases.
Current records show no registered clinical trials for hexarelin. There is no available trial sample data to summarize at this time.
No adverse event report data is available for hexarelin in the dataset reviewed. Without an approved label or trial safety data, no side effect profile can be summarized.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem
Updated 2026-11-07